P2RX4 and neoplasm: We demonstrated that two P2X4R selective antagonists (5-BDBD and PSB-12062) could both significantly reduce the ATP-induced calcium influx in PC3 cells, indicating that P2X4R was functional in PC3 cells and also that these two antagonists could be used for subsequent tumour biology studies to determine the activities of P2X4R.